首页> 外文期刊>European urology >Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth
【24h】

Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth

机译:通过纳入2014年国际泌尿病病理学术语分级和Cribriform Granging,改善术前列腺活检筛选前列腺癌症患者筛选前列腺癌症风险计算器的筛选欧洲随机研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The survival rate for men with International Society of Urological Pathology (ISUP) grade 2 prostate cancer (PCa) without invasive cribriform (CR) and intraductal carcinoma (IDC) is similar to that for ISUP grade 1. If updated into the European Randomized Study of Screening for Prostate Cancer (ERSPC Rotterdam) risk calculator number 3 (RC3), this may further improve upfront selection of men who need a biopsy.
机译:背景:具有国际泌尿病病理学(Isup)2级前列腺癌(PCA)的男性的生存率与没有侵入性的CRIBRIFIC(CR)和内部癌(IDC)类似于ISUP等级1.如果更新到欧洲随机化 前列腺癌筛选的研究(ERSPC鹿特丹)风险计算器第3号(RC3),这可能进一步改善需要活组织检查的男性的前期选择。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号